Boston Scientific (BSX) Reports In-Line Q3 EPS, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.31, in-line with the analyst estimate of $0.31. Revenue for the quarter came in at $2.22 billion versus the consensus estimate of $2.21 billion.
GUIDANCE:
Boston Scientific sees Q4 2017 EPS of $0.32-$0.35, versus the consensus of $0.34. Boston Scientific sees Q4 2017 revenue of $2.345-2.375 billion, versus the consensus of $2.33 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- SelectQuote, Inc. (SLQT) Tops Q1 EPS by 13c ; Offers Guidance
- Reynolds Consumer Products Inc. (REYN) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
